For any long term holder this announcement is a great milestone...

For any long term holder this announcement is a great milestone having our technology for the first time independently validated.

Keating sounded upbeat this morning and provided clarity around where the company is heading next:

- ISO audit to take place over the next few months will enable ResApp to submit for CE Mark & TGA using this set of data.
- Looking to commercialise in Europe initially using their German Hospital network as a footprint. Starting from early as next year
- US results expected later this month, they are currently finalising adjudication for the last set of patients. The criteria and study design mirrors Breathe Easy and these results will further be used to optimise our algorithms
- No CR was reaffirmed, Funding will take us past US analysis and results
- ResApp used iPhone 6S's for Breathe Easy which ran the algorithms, all the newer phones on both Android and iOS are continually being upgraded with higher fidelity microphones. Theres no issue with audio quality and it doesn't interfere with efficacy.

The volume tells me many were happy to give the stock away, herd mentality towards the end. We were trading higher than 23c pre Lockheed Martin announcement and results.

Theres not much now separating ResApp and stellar commercial success.